Atlas Trials

Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Clinical trial NCT00024440 · COMPLETED

Trial details

NCT number
NCT00024440
Sponsor
Genta Incorporated
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Leukemia
Start date
2001-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.